You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -864.3% | -2,327.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -15.3 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 51.4 | 100.0 |
| Price / Book value | 1.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 47.8% | -43.4% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -98.5% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 20.75 | -68.44 | $-0.16 | -13.7 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 9.81 | 478.47 | $1.49 | 2.8 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 11.77 | 18.97 | $0.02 | 273.3 | -2.8 | -99% | n/a | 0.0% |
| 2021-12-31 | 17.39 | -58.95 | $-0.21 | -18.8 | 0.0 | n/a | n/a | 0.0% |
| PureTech's Alkili reports success in adolescent ADHD study Sharecast News | 06 Jan |
|---|---|
| Puretech shares fall as Nektar Therapeutics merger talks end Sharecast News | 11 Oct |
| Puretech Health confirms possible tie-up with Nektar Therapeutics Sharecast News | 07 Oct |
| Transaction in Own Shares | 03-Feb-23 14:08 |
|---|---|
| Transaction in Own Shares | 02-Feb-23 14:10 |
| Total Voting Rights | 01-Feb-23 14:48 |
| Transaction in Own Shares | 01-Feb-23 14:48 |
| Transaction in Own Shares | 31-Jan-23 14:43 |